Development of a systematic theory of suspension inhalation aerosols. II. Aggregates of monodisperse particles nebulized in polydisperse droplets

No abstract is available for this paper.

• Publication year

  1988

• Venue

  International Journal of Pharmaceutics

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0378-5173(88)90147-0
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• MODEL OF AERODYNAMIC BEHAVIOUR OF AGGREGATES FORMED ON NEBULISATION OF SUSPENSIONS

  1985cited by this paper
• Development of a systematic theory of suspension inhalation aerosols. I. A framework to study the effects of aggregation on the aerodynamic behaviour of drug particles

  1985cited by this paper
• A statistical model for predicting the particle distribution of an atomised powder in liquid mixture

  1980cited by this paper
• The dilution of monodisperse suspensions for aerosolization.

  1968cited by this paper

• Nebulizers

  2024cites this paper
• Optical photothermal infrared spectroscopy for nanochemical analysis of pharmaceutical dry powder aerosols.

  2022cites this paper
• Co-spray dried hydrophobic drug formulations with crystalline lactose for inhalation aerosol delivery.

  2021cites this paper
• Raman spectroscopic evaluation of crystallinity, chemical composition and stability of pharmaceutical powder aerosols.

  2021cites this paper
• Bulk to nanometre-scale infrared spectroscopy of pharmaceutical dry powder aerosols.

  2020cites this paper
• Predicting the composition and size distribution of dry particles for aerosols and sprays of suspension: A Monte Carlo approach.

  2020cites this paper
• Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs

  2015cites this paper
• Modeling and Understanding Combination pMDI Formulations with Both Dissolved and Suspended Drugs.

  2015cites this paper
• Pharmaceutical Aerosols and Pulmonary Drug Delivery

  2014cites this paper
• Theoretical and experimental behavior of suspension pressurized metered dose inhalers

  2014influential citation
• Aerosol generation using nanometer liposome suspensions for pulmonary drug delivery applications

  2013cites this paper
• New inhalation-optimized itraconazole nanoparticle-based dry powders for the treatment of invasive pulmonary aspergillosis

  2012cites this paper
• A model for predicting size distributions delivered from pMDIs with suspended drug.

  2012cites this paper
• The Physics of Aerosol Droplet and Particle Generation from Inhalers

  2011cites this paper
• The influence of micronised particulates on the aerosolisation properties of pressurised metered dose inhalers

  2009cites this paper
• Improvement in the bioavailability of poorly water-soluble drugs via pulmonary delivery of nanoparticles

  2009cites this paper
• Investigations into the Formulation of Metered Dose Inhalers of Salmeterol Xinafoate and Fluticasone Propionate Microcrystals

  2008cites this paper
• High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers.

  2008cites this paper
• Studies in aerosol drug formulation, analysis, and modeling

  2008cites this paper
• Amorphous cyclosporin nanodispersions for enhanced pulmonary deposition and dissolution.

  2008cites this paper
• Development of a respirable, sustained release microcarrier for 5-fluorouracil II: In vitro and in vivo optimization of lipid coated nanoparticles.

  2006cites this paper
• Use of CP/MAS solid-state NMR for the characterization of solvate molecules within estradiol crystal forms.

  2005cites this paper
• Electrostatic charge characteristics of aerosols produced from metered dose inhalers.

  2005cites this paper
• Novel hydrofluoroalkane suspension formulations for respiratory drug delivery

  2005cites this paper
• Nanosuspensions in drug delivery

  2004cites this paper
• Nebulization of NanoCrystals™: Production of a Respirable Solid-in-Liquid-in-Air Colloidal Dispersion

  2004cites this paper
• Numerical simulations of crystal growth in a transdermal drug delivery system

  2004cites this paper
• Inhalation drug delivery devices and emerging technologies

  2003cites this paper
• Summary of common approaches to pharmaceutical aerosol administration

  2003cites this paper
• Polymeric Controlled Drug-Delivery Systems: Perspective Issues and Opportunities

  2001cites this paper
• Characterization of crystal forms of β-estradiol thermal analysis, Raman microscopy, X-ray analysis and solid-state NMR

  2000cites this paper
• Polystyrene Microsphere Spray Standards Based on CFC-Free Inhaler Technology

  2000cites this paper
• Transition to CFC-free metered dose inhalers--into the new millennium.

  2000cites this paper
• Drug-surfactant-propellant interactions in HFA-formulations.

  1999cites this paper
• Crystallization of β‐estradiol in an acrylic transdermal drug delivery system

  1999cites this paper
• PREDICTING REGIONAL LUNG DOSAGES OF A NEBULIZED SUSPENSION: PULMICORT® (BUDESONIDE)

  1997cites this paper
• Metered-dose inhalers, I: Drug content and particle size distribution of beclomethasone dipropionate.

  1996cites this paper
• Targeting by deposition

  1992cites this paper
• Aerodynamic properties of elongated particles of cromoglycic acid

  1989cites this paper
• Respirable form of crystals of cromoglycic acid.

  1989cites this paper